A screening program for colorectal cancer in chilean subjects aged fi fty years or more;Programa de detección de neoplasias colorrectales en población mayor de 50 años

Revista Medica de Chile

Volumn 140, Issue 3, 2012, Pages 281-286

  López Köstner, Francisco ^a   Kronberg, Udo ^a   Zárate, Alejandro J ^a   Wielandt, Ana María ^a   Pinto, Eliana ^a   Suazo, Cristobal ^a   Orellana, Paulina ^a   Avendaño, Rodolfo ^b   Bresky, Gustavo ^c   Castillo, Mirko ^d   Lubascher, Jaime ^a   Karelovic, Stanko ^e,f   Ross, Marcelo ^e,f   Ocares, Misael ^g   Riquelme, Fernando ^h,i   Contreras, Luis ^a   Vargas, Belisario ^j   Cortés, Miguel ^j  

^a CLÍNICA LAS CONDES   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c UNIVERSIDAD CATÓLICA DEL NORTE   (Chile)

^d Hospital Regional de Antofagasta   (Chile)

^e Hospital Regional de Punta Arenas   (Chile)

^f Clínica Magallanes de Punta Arenas   (Chile)

^g Hospital Regional Concepción   (Chile)

^h Hospital del Trabajador Concepción   (Chile)

ⁱ Hospital Gmo   (Chile)

^j Hospital del Cobre Dr Salvador Allende G   (Chile)

more..

Author keywords

Adenomatous polyps; Colonoscopy; Colorectal neoplasms

Indexed keywords

ADENOMATOUS POLYP; AGE; ARTICLE; CHILE; COLONOSCOPY; COLORECTAL TUMOR; EARLY DIAGNOSIS; HEALTH CARE QUALITY; HUMAN; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; OCCULT BLOOD; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RISK FACTOR; URBAN POPULATION; UTILIZATION REVIEW;

ADENOMATOUS POLYPS; AGE FACTORS; CHILE; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK FACTORS; URBAN POPULATION;

EID: 84862130336     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872012000300001     Document Type: Article

References (24)

1. Disponible en DEIS. Dirección: http://deis.minsal.cl/index.asp
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
3. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Costeffectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-61.
4. Ananda SS, McLaughlin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, et al. Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust 2009; 191: 378-81.
5. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
6. Bond JH. Fecal occult blood tests in occult gastrointestinal bleeding. Semin Gastrointest Dis 1999; 10: 48-52.
7. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
8. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
9. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
10. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007; 99: 1462-70.
11. Levin TR. Flexible sigmoidoscopy for colorectal cancer screening: valid approach or short-sighted? Gastroenterol Clin North Am 2002; 31: 1015-29.
12. Mergener K. The role of CT colonography in a colorectal cancer screening program. Gastrointest Endosc Clin N Am 2010; 20: 367-77.
13. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22: 191-7.
14. Greenwald B. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening. Gastroenterol Nurs 2005; 28: 90-6.
15. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 2005; 100: 2519-25.
16. Fenocchi E, Martínez L, Tolve J, Montano D, Rondán M, Parra-Blanco A, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev 2006; 15: 384-90.
17. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90.
18. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007; 56: 210-4.
19. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116: 544-73.
20. Ellul P, Fogden E, Simpson CL, Nickerson CL, McKaig BC, Swarbrick ET, et al. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: fi rst round data from the fi rst centre. Colorectal Dis 2010; 12: 420-2.
21. Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, et al. Results from the fi rst three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009; 58: 530-5.
22. Navarro M, Peris M, Binefa G, Vanaclocha M, Losa F, Fernández E. Colorectal cancer in a population with a guaiac-based screening programme. Med Clin (Barc) 2009; 132: 495-500.
23. Millard FB. Bowel cancer screening in Australia. Aust Fam Physician 2006; 35: 188-91.
24. Ginsberg GM, Lim SS, Lauer JA, Johns BP, Sepúlveda CR. Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis. Cost Eff Resour Alloc 2010; 8: 2.